tiprankstipranks
Trending News
More News >
Onconetix (ONCO)
NASDAQ:ONCO
US Market

Onconetix (ONCO) Income Statement

Compare
205 Followers

Onconetix Income Statement

Last quarter (Q3 2025), Onconetix's total revenue was $303.65K, a decrease of -25.37% from the same quarter last year. In Q3, Onconetix's net income was $-8.78M. See Onconetix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.52M$ 58.47K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 1.06M$ -1.13M$ -6.75K$ -4.89K$ -3.06K
Operating Expenses
$ 57.54M$ 34.91M$ 13.48M$ 3.42M$ 1.62M
Depreciation and Amortization
$ 731.35K$ 43.94K$ 6.75K$ 4.89K$ 3.06K
EBITDA
$ -57.60M$ -36.71M$ -13.41M$ -3.41M$ -1.60M
Operating Income
$ -56.49M$ -36.03M$ -13.48M$ -3.42M$ -1.62M
Other Income/Expenses
$ -3.25M$ -1.39M$ 61.41K$ 0.00$ 22.60K
Pretax Income
$ -59.74M$ -37.42M$ -13.42M$ -3.42M$ -1.60M
Net Income
$ -58.69M$ -37.41M$ -13.42M$ -3.42M$ -1.60M
Per Share Metrics
Basic EPS
$ -1.82K$ -87.60$ -1.09$ -0.31$ -0.14
Diluted EPS
$ -1.82K$ -87.60$ -1.09$ -0.31$ -0.14
Weighted Average Shares Outstanding
32.30K 5.03K 3.61K 3.25K 3.25K
Weighted Average Shares Outstanding (Diluted)
32.30K 5.03K 3.61K 3.25K 3.25K
Currency in USD

Onconetix Earnings and Revenue History